8 July 2021

The Swedish company NextCell Pharma AB acquired a block of shares in FamiCordTx S.A. owned by Polski Bank Komórek Macierzystych S.A.

Polski Bank Komórek Macierzystych, together with the Swedish company listed on the stock exchange, NextCell Pharma AB, will launch the production of the innovative CAR-T cell therapy. NextCell has just purchased a block of shares in the FamiCordTx company established two years ago – a company owned by Polski Bank Komórek Macierzystych (FamiCord Group). Loewen Legal Hub advised in this process.

Cooperation with this type of innovative companies is a great pleasure of participating in projects whose potential goes far beyond our “here and now” – emphasizes Szymon Kaczmarek, partner at Loewen Legal Hub, on whose behalf he handled this process.

Loewen Legal Hub specializes in handling all types of transactions on the capital market – domestic and foreign entities.